Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Zurich Insurance's sale of $20bn German life insurance book falls through

Published 30/01/2024, 08:28
© Reuters.
ZURVY
-

By John Revill and Alexander Hübner

ZURICH/MUNICH (Reuters) -Zurich Insurance on Tuesday said its plan to offload its $20 billion Zurich Life Legacy back book in Germany to Viridium Holding has fallen through after the insurance consolidator pulled out of the deal.

The Swiss insurance group said it was committed to finding a solution for the portfolio, which administers around 700,000 life insurance policies in Germany, and would continue to explore options.

Zurich's update came after a statement from Viridium which said the deal would not conclude "due to considerations relating to Viridium's current ownership structure".

The deal may have run aground due to concerns by authorities over Viridium's ownership by private equity company Cinven. The London private equity firm declined to comment on Tuesday.

According to two sources on Tuesday, German regulator BaFin has made it clear that it would block the deal, which was the reason for Viridium to pull out.

Potential concerns could have been the role Cinven played at Italian life insurer Eurovita, which it acquired in 2017 and which ran into difficulties last year due to rising interest rates.

Eurovita's capital needs were at least four times higher than the amount Cinven had put in to try and plug the shortfall. Cinven later agreed to buy back 160 million euros of debt to avoid a messy liquidation of the company.

The regulator declined to comment on Tuesday.

Reuters reported in October that Cinven, which owns a majority of Viridium, along with insurers Hannover Re and Assicurazioni Generali (BIT:GASI) who hold minority stakes, has begun exploring a sale of the company, which buys old books of insurance from other insurers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Such a transaction could eventually clear the way for Viridium to revive the Zurich deal.

"With a different owner the deal would have been approved," said a person familiar with the matter. "This will delay the next deals for Viridium until Cinven has sold their stake."

KBW Analyst Will Hawkins said the deal's collapse showed there was more regulatory resistance to private equity involvement than anticipated.

Zurich on Tuesday said the failure to offload the business would have no impact on its financial targets or capital management plans.

Zurich had announced the deal to sell legacy traditional life insurance back book for just under 500 million euros in June 2022.

The deal included the transfer of $20 billion of net reserves, mainly related to annuity and endowment products, Zurich said in 2022.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.